Impact of ADCY9 Genotype on Response to Anacetrapib-Reference-Cited by-同舟云学术

Impact of ADCY9 Genotype on Response to Anacetrapib

Published:2019-09-10 Issue:11 Volume:140 Page:891-898
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hopewell Jemma C.¹,Ibrahim Maysson¹,Hill Michael¹²,Shaw Peter M.³,Braunwald Eugene⁴,Blaustein Robert O.⁵,Bowman Louise¹²,Landray Martin J.¹,Sabatine Marc S.⁴,Collins Rory¹,Jiang L,Cannon CP,Wiviott SD,Armitage J,Haynes R,Maggioni AP,Angermann CE,Ertl G,Wanner C,Pedersen T,Goto S,Teramoto T,Baigent C,Barter P,Chen Y,Chen Z,Gray A,Mihaylova B,Sleight P,Tobert J,DeLucca P,Mitchel Y,van Leijenhorst G,

Affiliation:

1. Clinical Trial Service Unit and Epidemiological Studies Unit (J.C.H., M.I., M.H., L.B., M.J.L., R.C.), Nuffield Department of Population Health, University of Oxford, United Kingdom.

2. Medical Research Council Population Health Research Unit (M.H., L.B.), Nuffield Department of Population Health, University of Oxford, United Kingdom.

3. Department of Genetics and Pharmacogenomics (P.M.S.), Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ.

4. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (E.B., M.S.S.).

5. Cardiovascular Clinical Research (R.O.B.), Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

2. Effects of Torcetrapib in Patients at High Risk for Coronary Events

3. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

4. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

5. CETP

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Therapeutic Targets;Clinical Lipidology;2024

2. Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice;Canadian Journal of Cardiology;2023-07

3. Basics of pharmacogenomics;Pharmacogenomics;2023

4. CETP Inhibitors: Should We Continue to Pursue This Pathway?;Current Atherosclerosis Reports;2022-11-21

5. dal-GenE was negative—not positive except for COVID-19;European Heart Journal;2022-11-15